Key Points
-
Focuses on a condition that is being encountered with increasing frequency.
-
Highlights the importance of considering osteonecrosis as a differential diagnosis for orofacial pain.
-
Suggests possible management of osteonecrosis.
Abstract
Osteonecrosis of the jaws (ONJ) associated with bisphosphonate therapy is being reported with increasing frequency all over the world. Pain may be the presenting symptom commonly associated with intra-oral bone exposure. The aetiology of this therapeutic complication is still not well understood. Three cases are presented and the management of the condition is discussed.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Woo S -B, Hellstein J W, Kalmar J R . Systematic review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 2006; 144: 753–761.
Marx R E, Sawatari Y, Fortin M et al. Bisphosphonate-induced exposed bone (osteonecrosis/osteoporosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 2005; 63: 1567–1575.
Marx R E . Pamidronate (Aredia) and Zolendronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003; 61: 1115.
Rugerio S I, Mekrota B, Engroff S L . Osteonecrosis of the jaws associated with the use of bisphosphonates. A review of 63 cases. J Oral Maxillofac Surg 2004; 62: 527.
Migliorati C E . Bisphosphonates and oral cavity avascular bone necrosis. J Clin Oncol 2003; 21: 4253.
Migliorati C A, Casiglia J, Epstein J et al. Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper. J Am Dent Assoc 2005; 136: 1658–1668.
Author information
Authors and Affiliations
Corresponding author
Additional information
Refereed paper
Rights and permissions
About this article
Cite this article
Srinivasan, D., Shetty, S., Ashworth, D. et al. Orofacial pain – a presenting symptom of bisphosphonate associated osteonecrosis of the jaws. Br Dent J 203, 91–92 (2007). https://doi.org/10.1038/bdj.2007.635
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/bdj.2007.635
This article is cited by
-
Pain characteristics in medication-related osteonecrosis of the jaws
Supportive Care in Cancer (2021)
-
Standard protocols
British Dental Journal (2007)
